Stock Report

Download full stock data and analysis for free Last Updated: 11-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Zim Laboratories Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ZIMLAB | BSE: 541400

₹136.86

up-down-arrow ₹2.34 (1.74%)

As on 09-Nov-2026IST

Market cap

info icon

₹738 Cr

Revenue (TTM)

info icon

₹414 Cr

P/E Ratio

info icon

356.2

P/B Ratio

info icon

2.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 11.96 18.86 13.14 4.77 7.33
EBIT 62.24 -242.69 -63.86 -39.03 -18.19
Net Profit 48.93 -383.73 -68.56 -51.56 -19.93
EPS 49.09 -337.96 -65.27 -49.92 -18.32
Book Value -- -- 6.63 10.12 10.72
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 5.306.391.412.686.23
Net Margin info 3.063.930.491.513.16
Return on equity info 5.027.320.702.144.97
Return on Capital info 8.0410.64--5.478.29
Return on Assets info 2.693.940.411.152.64
Debt to Equity (x) info ----0.210.420.45

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
5.47
8.29
10.11
16.82
Peer Median
--
19.41
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

0.70

Lower than Peers by 14.48

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.70
2.14
4.97
7.86
13.00
Peer Median
15.19
18.29
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.41

Lower than Peers by 9.69

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.41
1.15
2.64
4.38
7.14
Peer Median
10.10
9.88
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

1.41

Lower than Peers by 17.15

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
1.41
2.68
6.23
6.91
8.66
Peer Median
18.57
18.50
18.93
21.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

0.49

Lower than Peers by 13.93

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.49
1.51
3.16
4.63
6.03
Peer Median
14.42
13.32
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
6.90
8.52
9.04
10.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

13.14

Higher than Peers by 1.01

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
13.14
-1.22
3.16
-7.80
19.52
Peer Median
12.13
13.53
10.90
13.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-63.86

Lower than Peers by 85.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
-63.86
-57.52
-6.97
-26.46
38.37
Peer Median
21.45
20.72
15.01
23.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-68.56

Lower than Peers by 91.15

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
-68.56
-52.01
-29.46
-29.42
67.93
Peer Median
22.58
18.73
14.80
30.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-65.27

Lower than Peers by 85.72

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
-65.27
-56.29
-29.46
-29.42
67.93
Peer Median
20.45
18.72
14.27
29.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
17.07
5.08
19.17
14.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.21

Higher than Peers by 0.21

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.21
0.42
0.45
0.44
0.30
Peer Median
0.00
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
0.21
0.21
0.23
0.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.37

Lower than Peers by 0.58

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
1.37
1.45
1.39
1.43
1.72
Peer Median
1.95
1.90
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.91

Lower than Peers by 0.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.91
0.96
0.87
0.92
1.24
Peer Median
1.48
1.40
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

1.19

Lower than Peers by 17.92

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
1.19
1.62
2.58
4.41
7.34
Peer Median
19.10
19.02
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

24.53

Higher than Peers by 2.88

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
24.53
29.12
28.21
27.26
23.90
Peer Median
21.65
19.75
21.77
20.10
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.81

Higher than Peers by 0.10

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
0.81
0.74
0.82
0.93
1.16
Peer Median
0.71
0.74
0.76
0.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
105.27
99.71
97.06
84.61
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
87.86
80.76
67.04
59.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
157.18
143.40
128.40
127.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
35.94
37.07
35.70
15.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

356.21

Higher than Peers by 320.75

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
356.21
54.87
32.12
26.98
14.44
Peer Median
35.46
34.26
26.81
39.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.52

Lower than Peers by 1.99

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
2.52
1.09
1.56
1.95
1.76
Peer Median
4.51
5.12
4.65
6.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
--
--
--
--
--
Peer Median
0.50
0.50
0.61
0.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

22.07

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
22.07
9.66
10.11
12.06
6.93
Peer Median
--
26.17
27.02
34.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

738

Lower than Peers by 17,538

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Zim Laboratories
738
320
391
465
353
Peer Median
18,276
17,931
20,914
25,297
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month